In addition, IL-6 limits anti-tumor T-cell responses by promoting the differentiation of M2 macrophages or acting on dendritic cells to inhibit the expression of MHC-II, CD80/86, and IL-12 and promote IL-10 production (Zhou et al., 2017). The gene discussed is CD80; the disease is neoplasm.